Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sol Carriazo

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|December 28, 2022
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney DiseaseJorge Rojas-Rivera, Sol Carriazo, Alberto Ortiz
The New England Journal of Medicine|January 26, 2021
Belimumab in Lupus NephritisJorge Rojas-Rivera, Alberto Ortiz, Sol Carriazo
Clinical Kidney Journal|September 8, 2020
Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrologySol Carriazo, Maria Vanessa Perez-Gomez, Alberto Ortiz
The New England Journal of Medicine|May 23, 2019
Diagnostic Utility of Exome Sequencing for Kidney DiseaseSol Carriazo, Alberto Ortiz, M Vanessa Perez-Gomez
Clinical Kidney Journal|October 5, 2019
Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normalJorge Enrique Rojas-Rivera, Sol Carriazo, Alberto Ortiz
Clinical Kidney Journal|May 2, 2022
Blood pressure targets in CKD 2021: the never-ending guidelines debacleSol Carriazo, Pantelis Sarafidis, Charles J Ferro, et al.
Clinical Kidney Journal|November 10, 2021
Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solvedPriscila Villalvazo, Sol Carriazo, Catalina Martin-Cleary, et al.
Clinical Kidney Journal|May 8, 2023
Tirzepatide and prevention of chronic kidney diseaseCatalina Bosch, Sol Carriazo, María José Soler, et al.
International Journal of Molecular Sciences|November 25, 2023
SCARF Genes in COVID-19 and Kidney Disease: A Path to Comorbidity-Specific TherapiesSol Carriazo, Daria Abasheva, Deborah Duarte, et al.
Lancet (London, England)|March 2, 2026
Autosomal dominant polycystic kidney diseaseAlbert C M Ong, Sol Carriazo, Becky Mingyao Ma, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|December 28, 2022
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney DiseaseJorge Rojas-Rivera, Sol Carriazo, Alberto Ortiz
The New England Journal of Medicine|January 26, 2021
Belimumab in Lupus NephritisJorge Rojas-Rivera, Alberto Ortiz, Sol Carriazo
Clinical Kidney Journal|September 8, 2020
Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrologySol Carriazo, Maria Vanessa Perez-Gomez, Alberto Ortiz
The New England Journal of Medicine|May 23, 2019
Diagnostic Utility of Exome Sequencing for Kidney DiseaseSol Carriazo, Alberto Ortiz, M Vanessa Perez-Gomez
Clinical Kidney Journal|October 5, 2019
Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normalJorge Enrique Rojas-Rivera, Sol Carriazo, Alberto Ortiz
Clinical Kidney Journal|May 2, 2022
Blood pressure targets in CKD 2021: the never-ending guidelines debacleSol Carriazo, Pantelis Sarafidis, Charles J Ferro, et al.
Clinical Kidney Journal|November 10, 2021
Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solvedPriscila Villalvazo, Sol Carriazo, Catalina Martin-Cleary, et al.
Clinical Kidney Journal|May 8, 2023
Tirzepatide and prevention of chronic kidney diseaseCatalina Bosch, Sol Carriazo, María José Soler, et al.
International Journal of Molecular Sciences|November 25, 2023
SCARF Genes in COVID-19 and Kidney Disease: A Path to Comorbidity-Specific TherapiesSol Carriazo, Daria Abasheva, Deborah Duarte, et al.
Lancet (London, England)|March 2, 2026
Autosomal dominant polycystic kidney diseaseAlbert C M Ong, Sol Carriazo, Becky Mingyao Ma, et al.
Pageof 5